Pharmafile Logo

OTC Awards

- PMLiVE

Is China ready for a pharmaceutical gold rush?

Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?

We’ve moved!

Blue Latitude Health has moved office to a new location in Barbican, Central London, following a year of substantial growth.

Blue Latitude Health

- PMLiVE

NICE appraisal fees to be introduced despite opposition

Concessions made for small companies

- PMLiVE

Dragonfly signs Celgene as partner for NK cell platform

Extends presence in haemato-oncology and solid tumours

- PMLiVE

AZ still sees route to approval for Imfinzi in MYSTIC trial

New analysis shows opportunity in NSCLC

- PMLiVE

AstraZeneca’s oncology renaissance

Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...

New editor adds microscopic attention to detail at Porterhouse Medical

The Porterhouse Medical Group is delighted to welcome Isabel Thomas to our scientific services team in Reading.Joining us as an associate editor, Isabel will be working closely alongside Stephanie, senior editor, to boost...

Porterhouse Medical Group

- PMLiVE

Brexit contributes to surge in generic drug prices

Calls for government to protect pharmacies

- PMLiVE

J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial

The majority of patients on Tremfya achieved at least a 90% improvement from PASI score

Navigating the antibiotic resistance crisis

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Blue Latitude Health

- PMLiVE

‘No deal’ Brexit could see pharmacists take lead amid drug shortages

Government steps up preparations as Brexit day nears

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links